HCA Healthcare, Inc. $HCA Shares Acquired by Norinchukin Bank The

Key Points

• Norinchukin Bank increased its stake in HCA Healthcare by 10.7%, purchasing an additional 770 shares, bringing its total holdings to 7,966 shares valued at approximately $2.75 million.
• Analysts have mixed opinions on HCA Healthcare, with ratings ranging from "strong buy" to "hold"**, and an average price target of $398.58.
• HCA Healthcare recently declared a quarterly dividend of $0.72 per share, representing a 0.7% yield, scheduled for payment on September 30th.

Norinchukin Bank The lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 10.7% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 7,966 shares of the company's stock after acquiring an additional 770 shares during the period. Norinchukin Bank The's holdings in HCA Healthcare were worth $2,753,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cheviot Value Management LLC purchased a new stake in HCA Healthcare in the 1st quarter valued at about $26,000. Atwood & Palmer Inc. purchased a new stake in HCA Healthcare in the 1st quarter valued at about $28,000. Bartlett & CO. Wealth Management LLC raised its holdings in HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after buying an additional 80 shares during the period. ORG Partners LLC raised its holdings in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after buying an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. increased its stake in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HCA has been the topic of a number of recent research reports. Barclays cut their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday, July 28th. Cantor Fitzgerald reiterated an "overweight" rating and set a $444.00 price target on shares of HCA Healthcare in a research note on Tuesday. Royal Bank Of Canada lowered their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research report on Monday, July 28th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Finally, Morgan Stanley lowered their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $401.83.

HCA Healthcare Stock Down 0.3%

HCA traded down $1.05 on Tuesday, reaching $401.72. The company's stock had a trading volume of 1,180,566 shares, compared to its average volume of 1,561,315. The stock has a 50 day moving average of $374.60 and a two-hundred day moving average of $354.80. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $94.00 billion, a price-to-earnings ratio of 16.89, a P/E/G ratio of 1.27 and a beta of 1.39. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.